Sc Us (Ttgp), Ltd. Guardant Health, Inc. Transaction History

Sc Us (Ttgp), Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $137 Million - $207 Million	-2,326,468 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $47.1 Million - $65.5 Million	-791,386 Reduced 25.38%	2,326,468 $182 Million
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $292 Million - $515 Million	-4,666,198 Reduced 59.95%	3,117,854 $199 Million
Q4 2018 Feb 14, 2019	BUY	$29.2 - $46.1 $227 Million - $359 Million	7,784,052 New	7,784,052 $293 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Sc Us (Ttgp), Ltd., based on Form 13F filings with the SEC.

Stay updated on Sc Us (Ttgp), Ltd. with notifications on news.